Durability of Antibody Response Against Hepatitis B Virus for a Decreased Crowd: A Retrospective Polycentric Cohort Study from a 10-Year Follow-Up Clinical Study.
Pei HeJie XiaPeixin ZhangWensu YangZhaoxin XiaPing LiuYi ZhuYaping FangZhen-Hua ZhangJilu ShenPublished in: Infection and drug resistance (2022)
To maintain optimal immunity against HBV infection, patients with a previous HBV history, those taking antiviral drugs, and/or those with low levels of HBsAb should be reimmunized with the hepatitis B vaccine in a timely manner.